Low‐factor consumption for major surgery in haemophilia B with long‐acting recombinant glyco<scp>PEG</scp>ylated factor <scp>IX</scp>

Abstract

These results indicated that nonacog beta pegol was safe and effective in the perioperative setting, allowing major surgical interventions in patients with haemophilia B with minimal peri- and postoperative concentrate consumption and infrequent injections as reported with standard FIX products.